Similarities between TNF inhibitor and Tuberculosis
TNF inhibitor and Tuberculosis have 3 things in common (in Unionpedia): Food and Drug Administration, Infliximab, Mycobacterium tuberculosis.
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Food and Drug Administration and TNF inhibitor · Food and Drug Administration and Tuberculosis ·
Infliximab
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
Infliximab and TNF inhibitor · Infliximab and Tuberculosis ·
Mycobacterium tuberculosis
Mycobacterium tuberculosis is a species of pathogenic bacteria in the family Mycobacteriaceae and the causative agent of tuberculosis.
Mycobacterium tuberculosis and TNF inhibitor · Mycobacterium tuberculosis and Tuberculosis ·
The list above answers the following questions
- What TNF inhibitor and Tuberculosis have in common
- What are the similarities between TNF inhibitor and Tuberculosis
TNF inhibitor and Tuberculosis Comparison
TNF inhibitor has 65 relations, while Tuberculosis has 237. As they have in common 3, the Jaccard index is 0.99% = 3 / (65 + 237).
References
This article shows the relationship between TNF inhibitor and Tuberculosis. To access each article from which the information was extracted, please visit: